Cite

HARVARD Citation

    Chen, Z. et al. (2021). Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma. Journal of oncology. p. . [Online]. 
  
Back to record